SCHEMBL10822239

SCHEMBL10822239

CNC(=O)c1c(O)ccc2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.56
ALOX15 P16050 1/20 0.51
ABCG2 Q9UNQ0 3/20 0.50
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 3/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
IDO1 P14902 1/20 0.48
HSD17B10 Q99714 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
PTPN22 Q9Y2R2 1/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HPGD P15428 2/20 0.45
GLA P06280 1/20 0.45
GAA P10253 1/20 0.45
HIF1A Q16665 1/20 0.44
ERN1 O75460 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8358481 0.85 ALOX15 (0.54) ALOX15ABCG2ALDH1A1KDM4EIDO1
SCHEMBL7189830 0.84 ABCG2 (0.55) ALOX15ABCG2ALDH1A1KDM4EIDO1
SCHEMBL1639535 0.82 ALOX15 (0.55) ALOX15ABCG2ALDH1A1KDM4EIDO1
SCHEMBL9243226 0.81 KDM4E (0.50) ALOX15ABCG2ALDH1A1KDM4EIDO1
SCHEMBL28517298 0.81 ABCG2 (0.49) ALOX15ABCG2ALDH1A1KDM4EIDO1
SCHEMBL13498479 0.81 MEN1 (0.50) ALOX15ABCG2ALDH1A1KDM4EIDO1
SCHEMBL29002134 0.81 PLK1 (0.54) PLK1ALDH1A1KDM4ENPC1RAB9A
Ammonia Solution, Strong SCHEMBL9297223 0.79 ALDH1A1 (0.59) ABCG2ALDH1A1KDM4EHSD17B10CYP1A2
SCHEMBL426582 0.79 ABCG2 (0.54) ABCG2ALDH1A1KDM4EHSD17B10CYP1A2
SCHEMBL30714893 0.79 ABCG2 (0.54) ABCG2ALDH1A1KDM4EHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-61075359-A None JP disclosed
CN-106187882-A Prepare method and the synthetic intermediate thereof of compound 克洛维斯肿瘤学意大利公司 2016-12-07 CN disclosed
US-20100028952-A1 FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES WYETH (US) 2010-02-04 US disclosed
US-20080274959-A1 Actinomadura Chromoprotein, Apoprotein and Gene Cluster WYETH (US) 2008-11-06 US disclosed
JP-S6175359-A PRODUCTION OF AZO PIGMENT AND ELECTROPHOTOGRAPHIC SENSITIVE BODY USING SAID AZO PIGMENT CANON INC 1986-04-17 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080274959-A1 Actinomadura Chromoprotein, Apoprotein and Gene Cluster ACTR2, APOB, CACYBP PLK1 4509/4885ALOX15 1760/4885ABCG2 2644/4885
US-20100028952-A1 FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES DCXR, ACTR2, AMY2A PLK1 4354/4885ALOX15 3120/4885ABCG2 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.